Antioxidant effects and mechanism of silymarin in oxidative stress induced cardiovascular diseases

Biomed Pharmacother. 2018 Jun:102:689-698. doi: 10.1016/j.biopha.2018.03.140. Epub 2018 Apr 5.

Abstract

Cardiovascular diseases (CVDs) are considered as the major reason for mortality and morbidity worldwide. Substantial evidence suggests that increased oxidative stress plays a significant role in the pathogenesis of CVDs, including atherosclerosis, hypertension, vascular endothelial dysfunction and ischemic heart disease. Cellular oxidative stress results in the release of toxic free radicals by endothelial cells and vascular smooth muscle cells that interact with cell components such as protein, DNA or lipid resulting in cardiovascular pathology. Silymarin has antioxidant activities against CVDs and offers protection against oxidative stress-induced hypertension, atherosclerosis and cardiac toxicity. We present a comprehensive review regarding the oxidative stress and protective effects of silymarin in CVDs management. We also aim to provide mechanistic insight of the mechanisms of silymarin action in oxidative stress-induced CVDs.

Keywords: Antioxidants; CVDs; Oxidative stress; ROS; Silymarin.

Publication types

  • Review

MeSH terms

  • Animals
  • Antioxidants / pharmacology
  • Antioxidants / therapeutic use*
  • Cardiovascular Diseases / drug therapy*
  • Cardiovascular Diseases / pathology*
  • Humans
  • Oxidative Stress* / drug effects
  • Protective Agents / pharmacology
  • Protective Agents / therapeutic use
  • Reactive Oxygen Species / metabolism
  • Silymarin / pharmacology
  • Silymarin / therapeutic use*

Substances

  • Antioxidants
  • Protective Agents
  • Reactive Oxygen Species
  • Silymarin